Kaplan-Meier curves revealed that a combined high expression of both ADAMTS12 and FBLN2 correlated with the best prognosis in breast cancer patients (Hts+Hfb, Fig. 6B) when compared to patients expressing low levels of both genes (Lts+Lfb) (p < 0.001). The gene discussed is ADAMTS12; the disease is breast carcinoma.